Stay updated on IMM-1-104 in RAS-Mutant Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the IMM-1-104 in RAS-Mutant Solid Tumors Clinical Trial page.

Latest updates to the IMM-1-104 in RAS-Mutant Solid Tumors Clinical Trial page
- Check3 days agoChange DetectedAdded a system-wide notice about a lapse in government funding and an update to the site revision (v3.4.1); the previous version (v3.4.0) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check10 days agoChange DetectedUI enhancements include a glossary display option and color-coded change highlights, with the revision label updated to v3.4.0. Substantive study data and content remain unchanged.SummaryDifference0.7%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page now shows a new revision entry (v3.3.4) replacing the previous v3.3.3; no substantive content changes are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision: v3.3.3 was added to the history, and the HHS Vulnerability Disclosure entry along with Revision: v3.3.2 were removed. These appear to be administrative updates and do not alter study details or how users access the record.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page history shows the addition of revision v3.3.2 and the removal of revision v3.2.0, indicating a routine site version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check81 days agoChange DetectedThe funding/operating status banner was removed from the page, while the rest of the study record content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to IMM-1-104 in RAS-Mutant Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMM-1-104 in RAS-Mutant Solid Tumors Clinical Trial page.